Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,672 total articles
Prestige Consumer Healthcare Inc. announced that its CEO and CFO will participate in a fireside chat at the Barclays Global Consumer Conference. The event will be webcast live and later available for replay. Prestige is a leading consumer healthcare company with a diverse portfolio of well-known brands.
Apnimed, a late-stage clinical pharmaceutical company focused on sleep-related breathing diseases, announced Q2 2026 financial results, highlighting FDA acceptance of the NDA for AD109 (Oxnimbi), an oral therapy targeting obstructive sleep apnea (OSA), with an FDA decision expected by February 28, 2027. The company completed a successful IPO, raisi…
Clearway Energy, Inc. has announced senior leadership changes including the appointment of Steven Ryder as CFO effective October 1, 2026, succeeding Sarah Rubenstein, who will lead the Transformation Office focusing on digital and data initiatives. Samantha Prout joins as Senior Vice President, Accounting and Controller. These changes aim to streng…
ImageneBio announces CEO Kristin Yarema's participation in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference in New York on September 14, 2026. The company is currently advancing its lead clinical asset, olevaprubart, a novel anti-OX40 monoclonal antibody for immunological and inflammatory diseases, undergoing Phase 2b…
Concentrix Corporation has acquired CastleHill Managed Risk Solutions, enhancing its enterprise risk, compliance, and AI governance capabilities. This acquisition strengthens Concentrix's offerings in Governance, Risk and Compliance (GRC), Third-Party Risk Management (TPRM), and AI risk management, especially in Banking, Financial Services, and Man…
Elevra Lithium Limited released a Pre-Feasibility Study (PFS) for the staged brownfield expansion of its North American Lithium (NAL) operation in Quebec. The expansion aims to nearly double spodumene concentrate annual production to 373,000 tonnes by 2029 and reduce unit operating costs significantly. The project has a total CAPEX of C$366M, is fu…
The Boston Beer Company, Inc. announced the appointment of Allison Stransky as Chief Marketing Officer effective October 12, 2026. Stransky brings over 20 years of experience including leadership roles at Samsung, Google, L'Oréal, Unilever, and Johnson & Johnson. She will lead marketing for the company's diverse portfolio of beer and beyond beer br…
Rocket Lab Corporation has announced the production release of IMM Apex, a next-generation high-efficiency solar cell for space applications that eliminates reliance on critical germanium substrates. IMM Apex delivers 31.5% efficiency, 40% lower mass, and is compatible as a drop-in replacement for existing systems. The new cell technology aims to r…
BullFrog AI Holdings, Inc. announces its participation in two leading investor conferences in September 2026, where CEO Vin Singh will present the company's AI capabilities in biomedical data analytics to institutional investors, aiming to increase visibility and investor engagement.
Ryman Hospitality Properties, Inc., a US-based hospitality REIT specializing in upscale convention center resorts and entertainment experiences, announced that it will release its Q3 2026 earnings after market close on November 2, 2026, followed by a conference call on November 3, 2026. The company manages a large portfolio of group-oriented hotels…
Celestica Inc., a publicly traded company on the NYSE and TSX under the ticker CLS, has announced its 2026 Investor and Analyst Day to be held on October 27, 2026. The event will include a virtual presentation alongside the third quarter 2026 financial results conference call, followed by an in-person Lunch Forum in Midtown Manhattan. This forum wi…
Evolution Petroleum Corporation scheduled to release its financial and operating results for Q4 and full year 2026 on September 15, 2026. A conference call with top executives will follow on September 16 to discuss the results.
Fuel Tech, Inc., a Nasdaq-listed clean technology company specializing in emissions control and water treatment solutions, announced the appointment of Sharon L. Jones as Chair of the Board effective September 15, 2026. Jones takes over from Vincent J. Arnone, who retired as President and CEO but remains on the Board. The leadership change signals …
Smithfield Foods, Inc. has provided an updated third-quarter outlook ahead of the Barclays Global Consumer Staples Conference. The company now anticipates a significant adjusted operating loss in its Fresh Pork segment due to further compression in the industry pork market spread and lower USDA pork cutout prices. Hog Production segment profits are…
InterCure Ltd., a leading cannabis company, announced it has regained compliance with Nasdaq's minimum bid price requirement after its stock price surpassed $1.00 for ten consecutive business days, preventing delisting from The Nasdaq Global Market.
Espey Mfg. & Electronics Corp. announced a special cash dividend of $0.75 per share in addition to its regular quarterly dividend of $0.25 per share, payable September 25, 2026. Concurrently, Kaitlyn O'Neil was promoted to Chief Financial Officer, strengthening the company's financial leadership as it pursues growth and strategic objectives in mili…
Sun Communities, Inc., a real estate investment trust specializing in manufactured housing and RV communities, announced a third quarter 2026 distribution of $1.12 per common share payable on October 15, 2026. The announcement demonstrates the company’s continued commitment to returning value to shareholders from its extensive portfolio of properti…
Korsana Biosciences finalized its merger with Cyclerion Therapeutics and completed a $380 million private financing, positioning the company with approximately $475 million in cash to fund operations into 2029. The combined company will begin trading on Nasdaq under ticker KRSA starting September 9, 2026. Korsana’s lead program, KRSA-028, a next-ge…
CAMP4 Therapeutics announced a virtual Analyst Day on September 28, 2026, to present details on CMP-002, a novel antisense oligonucleotide therapeutic designed to treat SYNGAP1-related disorder, a rare genetic condition with no approved disease-modifying therapies. The company plans to initiate a Phase 1/2 clinical trial of CMP-002 in Q4 2026 and w…
Barnes & Noble Education (NYSE: BNED) reported fiscal 2027 first quarter results with a 29% improvement in net income (loss) and 19% improvement in adjusted EBITDA year-over-year. Revenue rose slightly to $290.6 million, driven by growth in the BNC First Day® Complete program, which will reach an estimated 1.43 million students this fall — a 26% in…
ServiceTitan, a leading software platform for contractors and trades, announced its fiscal second quarter 2027 financial results highlighting 21% year-over-year revenue growth to $292.8 million and generating over $50 million in non-GAAP free cash flow. The company emphasized accelerating adoption of its AI-enhanced Agentic Operating System, with o…
ServiceTitan named Rikus Pretorius, former Senior Vice President of Worldwide Sales, as its new Chief Revenue Officer effective from the start of the fiscal fourth quarter. Pretorius succeeds Ross Biestman, who is stepping back from day-to-day operations after nearly a decade as CRO but will remain an advisor through fiscal 2027 to ensure a smooth …
Protara Therapeutics, a clinical-stage biotech company specializing in transformative therapies for cancer and rare diseases, announced management will present at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation will cover their clinical pipeline including TARA-002, focused on non-muscle invasive bladder cancer and lym…
InnovAge Holding Corp. announced its financial results for the fiscal year ended June 30, 2026, highlighting a strong turnaround with nearly $990 million in revenues, a marginal net loss of $0.7 million compared to a $35.3 million loss the prior year, and increased Adjusted EBITDA of $94.6 million. The company also issued optimistic financial guida…
Journey Medical Corporation, a Nasdaq-listed pharmaceutical company specializing in FDA-approved dermatology prescription products, announced CEO Claude Maraoui's participation in two investor conferences in September 2026. The company will present at the Lake Street Capital Markets 10th Annual Best Ideas Growth Conference and the H.C. Wainwright 2…
